SciencePower’s Sequential Fermentation Technology for Postbiotics
BEVERAGESCONFECTIONARYNUTRACEUTICALSDAIRY & ALTERNATIVES MOST POPULAR


This is an AI generated illustration and does not represent actual product or service.
In the rapidly evolving field of microbiome science, SciencePower, an Italy-based biotech startup, has developed a postbiotic technology that promises to redefine gut health and beyond. Unlike traditional probiotics, which rely on live microorganisms, SciencePower’s patent-pending (US20250114409A1) Sequential Fermentation Technology produces highly bioactive, stable, and safe postbiotic compositions with superior efficacy.
This innovation addresses key limitations of probiotics—such as poor heat stability, short shelf life, and safety concerns in immunocompromised individuals—while delivering targeted, potent health benefits across multiple industries, including food & beverage, supplements, cosmetics, therapeutics, and pet nutrition.
The Science Behind Postbiotics
Probiotics, defined as live microorganisms that confer health benefits, have long been used to support gut health. However, they face challenges:
Low stability (sensitive to heat, stomach acid, and storage conditions).
Limited shelf life (viability declines over time).
Safety risks (potential infections in immunocompromised individuals).
Postbiotics, on the other hand, are preparations of inanimate microorganisms and their metabolites that retain beneficial effects without the drawbacks of live bacteria. The International Scientific Association for Probiotics and Prebiotics (ISAPP) defines postbiotics as:
“A preparation of inanimate microorganisms and/or their components that confer a health benefit on the host.”
This includes:
Cell wall components (peptidoglycans, teichoic acids).
Metabolites (short-chain fatty acids, lactic acid, antimicrobial peptides).
Functional proteins and polysaccharides.
Why SciencePower’s Approach is Unique
Most postbiotic products today are derived from single-strain fermentations, limiting their bioactive potential. SciencePower’s Sequential Fermentation Technology overcomes this by:
Parallel Fermentation: Multiple microorganisms are fermented separately, inactivated, and then combined—ensuring no competition or metabolic interference.
Serial Fermentation: A stepwise fermentation process where one microorganism’s fermented matrix becomes the substrate for the next, amplifying bioactive diversity.
This method enhances synergistic effects, creating postbiotics with greater stability, potency, and functionality than single-strain alternatives.
Key Innovations & Benefits
1. Enhanced Bioactivity & Immune Modulation
SciencePower’s postbiotics stimulate innate immunity more effectively than single-strain probiotics or traditional postbiotics. In human enterocyte (Caco-2) studies:
3x higher β-defensin-2 (HBD-2) production (a key antimicrobial peptide).
Increased expression of tight junction proteins (occludin, ZO-1) and mucin (MUC5AC), strengthening the gut barrier.
Boosted cathelicidin LL-37, enhancing antimicrobial defense.
2. Superior Stability & Safety
Heat-resistant (unlike live probiotics).
Longer shelf life (no viability concerns).
Safe for immunocompromised patients (no risk of bacterial translocation).
3. Multi-Strain Synergy for Targeted Benefits
SciencePower’s postbiotics combine Lactobacillus, Bifidobacterium, Akkermansia, and E. coli Nissle 1917, covering key phyla of the gut microbiome.
Commercial Applications & Market Potential
SciencePower’s technology is versatile and scalable, making it ideal for:
1. Functional Foods & Beverages
Fermented drinks, yogurts, snack bars with enhanced gut health benefits.
Heat-stable for pasteurized products.
2. Dietary Supplements
Postbiotic capsules, powders, gummies with higher efficacy at lower doses.
Combination products (e.g., postbiotics + prebiotics, vitamins).
3. Cosmetics & Skincare
Probiotic-free skincare with anti-inflammatory and barrier-enhancing effects.
4. Therapeutics
Supportive therapy for IBD, IBS, and metabolic disorders.
Adjuvant for antibiotic recovery.
5. Pet & Livestock Nutrition
Improves gut health in animals without refrigeration needs.
Conclusion: The Future of Postbiotics
SciencePower’s Sequential Fermentation Technology represents a paradigm shift in microbiome science. By harnessing the power of multi-strain postbiotics, the company delivers:
✅ Greater potency than single-strain probiotics.
✅ Unmatched stability for global distribution.
✅ Adaptability across industries.
As research continues to validate postbiotics’ role in immune health, gut-brain axis modulation, and chronic disease prevention, SciencePower is poised to lead this revolution—offering science-backed, next-generation solutions for a healthier future.





